Ice breaking in GPCR structural biology

Acta Pharmacologica Sinica

Volumn 33, Issue 3, 2012, Pages 324-334

  Zhao, Qiang ^a   Wu, Bei Li ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

bicelle; crystallization; expression study; G protein coupled receptors (GPCRs); lipidic cubic phase; mutagenesis; surfactant

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR;

CRYSTAL STRUCTURE; CRYSTALLIZATION; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

GTP-BINDING PROTEINS; HUMANS; PROTEIN CONFORMATION; RECEPTORS, CXCR4; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84858120018     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.187     Document Type: Review

References (90)

1. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000; 289: 739-45. (Pubitemid 30650186)
2. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007; 318: 1258-65. (Pubitemid 350172884)
3. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008; 322: 1211-7.
4. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, et al. Structure of a beta1-adrenergic G-proteincoupled receptor. Nature 2008; 454: 486-91.
5. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010; 330: 1066-71.
6. Chien EY, Liu W, Zhao Q, Katritch V, Han GW, Hanson MA, et al. Structure of the human dopamine D3 receptor in complex with a D2/ D3 selective antagonist. Science 2010; 330: 1091-5.
7. Shimamura T, Shiroishi M, Weyand S, Tsujimoto H, Winter G, Katritch V, et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011; 475: 65-70.
8. Lundstrom K. Structural genomics of GPCRs. Trends Biotechnol 2005; 23: 103-8. (Pubitemid 40127346)
9. Bockenhauer S, Furstenberg A, Yao XJ, Kobilka B, Moerner WE. Conformational dynamics of single G protein-coupled receptors in solution. J Phys Chem B 2011; 115: 13328-38.
10. Rasmussen SG, Choi HJ, Fung JJ, Pardon E, Casarosa P, Chae PS, et al. Structure of a nanobody-stabilized active state of the beta2 adrenoceptor. Nature 2011; 469: 175-80.
11. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011; 477: 549-55.
12. Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008; 454: 183-7. (Pubitemid 351969893)
13. Deupi X, Kobilka BK. Energy landscapes as a tool to integrate GPCR structure, dynamics, and function. Physiology (Bethesda) 2010; 25: 293-303.
14. Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao ZG, et al. Structure of an agonist-bound human A2A adenosine receptor. Science 2011; 332: 322-7.
15. Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH, et al. Structure and function of an irreversible agonist-beta(2) adrenoceptor complex. Nature 2011; 469: 236-40.
16. Dore AS, Robertson N, Errey JC, Ng I, Hollenstein K, Tehan B, et al. Structure of the adenosine A2A receptor in complex with ZM241385 and the xanthines XAC and caffeine. Structure 2011; 19: 1283-93.
17. Reeves PJ, Kim JM, Khorana HG. Structure and function in rhodopsin: a tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants. Proc Natl Acad Sci U S A 2002; 99: 13413-8. (Pubitemid 35215395)
18. Kempf J, Snook LA, Vonesch JL, Dahms TE, Pattus F, Massotte D. Expression of the human mu opioid receptor in a stable Sf9 cell line. J Biotechnol 2002; 95: 181-7. (Pubitemid 34241557)
19. Hanson MA, Brooun A, Baker KA, Jaakola VP, Roth C, Chien EY, et al. Profiling of membrane protein variants in a baculovirus system by coupling cell-surface detection with small-scale parallel expression. Protein Expr Purif 2007; 56: 85-92. (Pubitemid 47499088)
20. Reilander H, Weiss HM. Production of G-protein-coupled receptors in yeast. Curr Opin Biotechnol 1998; 9: 510-7. (Pubitemid 28478974)
21. Kaushal S, Ridge KD, Khorana HG. Structure and function in rhodopsin: the role of asparagine-linked glycosylation. Proc Natl Acad Sci U S A 1994; 91: 4024-8. (Pubitemid 24139565)
22. Lagane B, Gaibelet G, Meilhoc E, Masson JM, Cezanne L, Lopez A. Role of sterols in modulating the human mu-opioid receptor function in Saccharomyces cerevisiae. J Biol Chem 2000; 275: 33197-200.
23. King K, Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Control of yeast mating signal transduction by a mammalian beta 2-adrenergic receptor and Gs alpha subunit. Science 1990; 250: 121-3. (Pubitemid 20374972)
24. Payette P, Gossard F, Whiteway M, Dennis M. Expression and pharmacological characterization of the human M1 muscarinic receptor in Saccharomyces cerevisiae. FEBS Lett 1990; 266: 21-5. (Pubitemid 20194163)
25. Talmont F, Sidobre S, Demange P, Milon A, Emorine LJ. Expression and pharmacological characterization of the human mu-opioid receptor in the methylotrophic yeast Pichia pastoris. FEBS Lett 1996; 394: 268-72. (Pubitemid 26341456)
26. Beukers MW, Klaassen CH, De Grip WJ, Verzijl D, Timmerman H, Leurs R. Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cells. Br J Pharmacol 1997; 122: 867-74. (Pubitemid 27460168)
27. Weiss HM, Haase W, Reilander H. Expression of an integral membrane protein, the 5HT5A receptor. Methods Mol Biol 1998; 103: 227-39.
28. Sarramegna V, Talmont F, Seree de Roch M, Milon A, Demange P. Green fluorescent protein as a reporter of human mu-opioid receptor overexpression and localization in the methylotrophic yeast Pichia pastoris. J Biotechnol 2002; 99: 23-39. (Pubitemid 35223039)
29. Mollaaghababa R, Davidson FF, Kaiser C, Khorana HG. Structure and function in rhodopsin: expression of functional mammalian opsin in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 1996; 93: 11482-6. (Pubitemid 26347147)
30. Asada H, Uemura T, Yurugi-Kobayashi T, Shiroishi M, Shimamura T, Tsujimoto H, et al. Evaluation of the pichia pastoris expression system for the production of GPCRs for structural analysis. Microb Cell Fact 2011; 10: 24.
31. O'Malley MA, Mancini JD, Young CL, McCusker EC, Raden D, Robinson AS. Progress toward heterologous expression of active G-proteincoupled receptors in Saccharomyces cerevisiae: Linking cellular stress response with translocation and trafficking. Protein Sci 2009; 18: 2356-70.
32. Shukla AK, Haase W, Reinhart C, Michel H. Heterologous expression and comparative characterization of the human neuromedin U subtype II receptor using the methylotrophic yeast Pichia pastoris and mammalian cells. Int J Biochem Cell Biol 2007; 39: 931-42. (Pubitemid 46575324)
33. Butz JA, Niebauer RT, Robinson AS. Co-expression of molecular chaperones does not improve the heterologous expression of mammalian G-protein coupled receptor expression in yeast. Biotechnol Bioeng 2003; 84: 292-304. (Pubitemid 37221531)
34. Zhang R, Kim TK, Qiao ZH, Cai J, Pierce WM Jr, Song ZH. Biochemical and mass spectrometric characterization of the human CB2 cannabinoid receptor expressed in Pichia pastoris -importance of correct processing of the N-terminus. Protein Expr Purif 2007; 55: 225-35. (Pubitemid 47369645)
35. Bertin B, Freissmuth M, Breyer RM, Schutz W, Strosberg AD, Marullo S. Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem 1992; 267: 8200-6.
36. Grisshammer R, Duckworth R, Henderson R. Expression of a rat neurotensin receptor in Escherichia coli. Biochem J 1993; 295: 571-6. (Pubitemid 23315200)
37. Serrano-Vega MJ, Magnani F, Shibata Y, Tate CG. Conformational thermostabilization of the beta1-adrenergic receptor in a detergentresistant form. Proc Natl Acad Sci U S A 2008; 105: 877-82. (Pubitemid 351282049)
38. Sarkar CA, Dodevski I, Kenig M, Dudli S, Mohr A, Hermans E, et al. Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity. Proc Natl Acad Sci U S A 2008; 105: 14808-13.
39. Dodevski I, Pluckthun A. Evolution of three human GPCRs for higher expression and stability. J Mol Biol 2011; 408: 599-615.
40. Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, et al. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science 2007; 318: 1266-73. (Pubitemid 350172885)
41. Alexandrov AI, Mileni M, Chien EY, Hanson MA, Stevens RC. Microscale fluorescent thermal stability assay for membrane proteins. Structure 2008; 16: 351-9. (Pubitemid 351324124)
42. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007; 450: 383-7. (Pubitemid 350126755)
43. Ballesteros J, Weinstein H. Integrated methods for the construction of three-dimensional models and computational probing of structurefunction relations in G protein-coupled receptors. Methods Neurosci 1995; 25: 366-428.
44. Roth CB, Hanson MA, Stevens RC. Stabilization of the human beta2-adrenergic receptor TM4-TM3-TM5 helix interface by mutagenesis of Glu122(3.41), a critical residue in GPCR structure. J Mol Biol 2008; 376: 1305-19.
45. Lebon G, Bennett K, Jazayeri A, Tate CG. Thermostabilisation of an agonist-bound conformation of the human adenosine A2A receptor. J Mol Biol 2011; 409: 298-310.
46. Shibata Y, White JF, Serrano-Vega MJ, Magnani F, Aloia AL, Grisshammer R, et al. Thermostabilization of the neurotensin receptor NTS1. J Mol Biol 2009; 390: 262-77.
47. Hong WX, Baker KA, Ma X, Stevens RC, Yeager M, Zhang Q. Design, synthesis, and properties of branch-chained maltoside detergents for stabilization and crystallization of integral membrane proteins: human connexin 26. Langmuir 2010; 26: 8690-6.
48. Chae PS, Rasmussen SG, Rana RR, Gotfryd K, Chandra R, Goren MA, et al. Maltose-neopentyl glycol (MNG) amphiphiles for solubilization, stabilization and crystallization of membrane proteins. Nat Methods 2010; 7: 1003-8.
49. Bayburt TH, Sligar SG. Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers. Protein Sci 2003; 12: 2476-81. (Pubitemid 37310788)
50. Nath A, Atkins WM, Sligar SG. Applications of phospholipid bilayer nanodiscs in the study of membranes and membrane proteins. Biochemistry 2007; 46: 2059-69. (Pubitemid 46355317)
51. Tribet C, Audebert R, Popot JL. Amphipols: polymers that keep membrane proteins soluble in aqueous solutions. Proc Natl Acad Sci U S A 1996; 93: 15047-50. (Pubitemid 27009549)
52. Gorzelle BM, Hoffman AK, Keyes MH, Gray DN, Ray DG, Sanders CR. Amphipols can support the activity of a membrane enzyme. J Am Chem Soc 2002; 124: 11594-5.
53. Breyton C, Pucci B, Popot JL. Amphipols and fluorinated surfactants: Two alternatives to detergents for studying membrane proteins in vitro. Methods Mol Biol 2010; 601: 219-45.
54. Schafmeister CE, Miercke LJ, Stroud RM. Structure at 2.5 A of a designed peptide that maintains solubility of membrane proteins. Science 1993; 262: 734-8. (Pubitemid 23350691)
55. McGregor CL, Chen L, Pomroy NC, Hwang P, Go S, Chakrabartty A, et al. Lipopeptide detergents designed for the structural study of membrane proteins. Nat Biotechnol 2003; 21: 171-6. (Pubitemid 36188216)
56. Kiley P, Zhao X, Vaughn M, Baldo MA, Bruce BD, Zhang S. Selfassembling peptide detergents stabilize isolated photosystem I on a dry surface for an extended time. PLoS Biol 2005; 3: e230.
57. Barthelemy P, Ameduri B, Chabaud E, Popot JL, Pucci B. Synthesis and preliminary assessments of ethyl-terminated perfluoroalkyl nonionic surfactants derived from tris(hydroxymethyl)acrylamidomethane. Org Lett 1999; 1: 1689-92.
58. McQuade DT, Quinn MA, Yu SM, Polans AS, Krebs MP, Gellman SH. Rigid amphiphiles for membrane protein manipulation. Angew Chem Int Ed Engl 2000; 39: 758-61. (Pubitemid 30216743)
59. Chae PS, Wander MJ, Bowling AP, Laible PD, Gellman SH. Glycotripod amphiphiles for solubilization and stabilization of a membrane-protein superassembly: importance of branching in the hydrophilic portion. Chembiochem 2008; 9: 1706-9.
60. Zhang Q, Ma X, Ward A, Hong WX, Jaakola VP, Stevens RC, et al. Designing facial amphiphiles for the stabilization of integral membrane proteins. Angew Chem Int Ed Engl 2007; 46: 7023-5. (Pubitemid 47492227)
61. Chae PS, Gotfryd K, Pacyna J, Miercke LJ, Rasmussen SG, Robbins RA, et al. Tandem facial amphiphiles for membrane protein stabilization. J Am Chem Soc 2010; 132: 16750-2.
62. Wu H, Su K, Guan X, Sublette ME, Stark RE. Assessing the size, stability, and utility of isotropically tumbling bicelle systems for structural biology. Biochim Biophys Acta 2010; 1798: 482-8.
63. Faham S, Bowie JU. Bicelle crystallization: a new method for crystallizing membrane proteins yields a monomeric bacteriorhodopsin structure. J Mol Biol 2002; 316: 1-6. (Pubitemid 34729261)
64. Arnold A, Labrot T, Oda R, Dufourc EJ. Cation modulation of bicelle size and magnetic alignment as revealed by solid-state NMR and electron microscopy. Biophys J 2002; 83: 2667-80. (Pubitemid 35265759)
65. Faham S, Boulting GL, Massey EA, Yohannan S, Yang D, Bowie JU. Crystallization of bacteriorhodopsin from bicelle formulations at room temperature. Protein Sci 2005; 14: 836-40. (Pubitemid 40283923)
66. Bayburt TH, Sligar SG. Membrane protein assembly into Nanodiscs. FEBS Lett 2010; 584: 1721-7.
67. Borch J, Hamann T. The nanodisc: a novel tool for membrane protein studies. Biol Chem 2009; 390: 805-14.
68. Leitz AJ, Bayburt TH, Barnakov AN, Springer BA, Sligar SG. Functional reconstitution of beta2-adrenergic receptors utilizing self-assembling Nanodisc technology. Biotechniques 2006; 40: 601-2.
69. Borch J, Roepstorff P, Moller-Jensen J. Nanodisc-based co-immunoprecipitation for mass spectrometric identification of membraneinteracting proteins. Mol Cell Proteomics 2011; 10: O110.006775.
70. Wohri AB, Johansson LC, Wadsten-Hindrichsen P, Wahlgren WY, Fischer G, Horsefield R, et al. A lipidic-sponge phase screen for membrane protein crystallization. Structure 2008; 16: 1003-9. (Pubitemid 351899294)
71. Caffrey M. Crystallizing membrane proteins for structure determination: use of lipidic mesophases. Annu Rev Biophys 2009; 38: 29-51.
72. Caffrey M, Cherezov V. Crystallizing membrane proteins using lipidic mesophases. Nat Protoc 2009; 4: 706-31.
73. Li D, Lee J, Caffrey M. Crystallizing membrane proteins in lipidic mesophases. A host lipid screen. Cryst Growth Des 2011; 11: 530-7.
74. Qiu H, Caffrey M. Lyotropic and thermotropic phase behavior of hydrated monoacylglycerols: structure characterization of monovaccenin. J Phys Chem B 1998; 102: 4819-29. (Pubitemid 128611711)
75. Landau EM, Rosenbusch JP. Lipidic cubic phases: a novel concept for the crystallization of membrane proteins. Proc Natl Acad Sci U S A 1996; 93: 14532-5. (Pubitemid 26419001)
76. Pebay-Peyroula E, Rummel G, Rosenbusch JP, Landau EM. X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. Science 1997; 277: 1676-81. (Pubitemid 27446232)
77. Cherezov V, Clogston J, Papiz MZ, Caffrey M. Room to move: crystallizing membrane proteins in swollen lipidic mesophases. J Mol Biol 2006; 357: 1605-18.
78. Grabe M, Neu J, Oster G, Nollert P. Protein interactions and membrane geometry. Biophys J 2003; 84: 854-68. (Pubitemid 36133413)
79. Templer RH, Seddon JM, Duesing PM. Modeling the phase behavior of the inverse hexagonal and inverse bicontinuous cubic phases in 2:1 fatty acid/phosphatidylcholine mixtures. J Phys Chem B 1998; 102: 7262-71. (Pubitemid 128586729)
80. Misquitta Y, Caffrey M. Detergents destabilize the cubic phase of monoolein: implications for membrane protein crystallization. Biophys J 2003; 85: 3084-96. (Pubitemid 37345796)
81. Wadsten-Hindrichsen P, Bender J, Unga J, Engstrom S. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. J Colloid Interface Sci 2007; 315: 701-13. (Pubitemid 47445546)
82. Cherezov V, Liu J, Griffith M, Hanson MA, Stevens RC. LCP-FRAP assay for pre-screening membrane proteins for in meso crystallization. Cryst Growth Des 2008; 8: 4307-15.
83. Xu F, Liu W, Hanson MA, Stevens RC, Cherezov V. Development of an automated high throughput LCP-FRAP assay to guide membrane protein crystallization in lipid mesophases. Cryst Growth Des 2011; 11: 1193-201.
84. Liu W, Hanson MA, Stevens RC, Cherezov V. LCP-Tm: an assay to measure and understand stability of membrane proteins in a membrane environment. Biophys J 2010; 98: 1539-48.
85. Cherezov V, Peddi A, Muthusubramaniam L, Zheng YF, Caffrey M. A robotic system for crystallizing membrane and soluble proteins in lipidic mesophases. Acta Crystallogr D Biol Crystallogr 2004; 60: 1795-807. (Pubitemid 41079701)
86. Bowler MW, Guijarro M, Petitdemange S, Baker I, Svensson O, Burghammer M, et al. Diffraction cartography: applying microbeams to macromolecular crystallography sample evaluation and data collection. Acta Crystallogr D Biol Crystallogr 2010; 66: 855-64.
87. Kraft P, Bergamaschi A, Broennimann C, Dinapoli R, Eikenberry EF, Henrich B, et al. Performance of single-photon-counting PILATUS detector modules. J Synchrotron Radiat 2009; 16: 368-75.
88. Cherezov V, Hanson MA, Griffith MT, Hilgart MC, Sanishvili R, Nagarajan V, et al. Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 microm size X-ray synchrotron beam. J R Soc Interface 2009; 6: S587-97.
89. Mader K, Marone F, Hintermuller C, Mikuljan G, Isenegger A, Stampanoni M. High-throughput full-automatic synchrotron-based tomographic microscopy. J Synchrotron Radiat 2011; 18: 117-24.
90. Joachimiak A. High-throughput crystallography for structural genomics. Curr Opin Struct Biol 2009; 19: 573-84.